{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:15Z","timestamp":1793949555690,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["IIRG-12\u2013247219"],"award-info":[{"award-number":["IIRG-12\u2013247219"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-07-59514"],"award-info":[{"award-number":["NIRG-07-59514"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neurobiolaging.2013.10.076","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T14:16:42Z","timestamp":1381501002000},"page":"793-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition"],"prefix":"10.1016","volume":"35","author":[{"given":"Brittany L.","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Yarchoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Min","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Louneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung-gon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Casadesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib1","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.040577797","article-title":"Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5","volume":"97","author":"Ahlijanian","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","article-title":"Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory\u2019","volume":"1","author":"Bevins","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.exger.2005.05.007","article-title":"The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer\u2019s disease","volume":"40","author":"Butterfield","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.28.3.632","article-title":"Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes","volume":"28","author":"Ceriello","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib9","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1523\/JNEUROSCI.0689-08.2008","article-title":"Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2","volume":"28","author":"Cheung","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib10","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1242\/jcs.035063","article-title":"Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment","volume":"121","author":"Corradi","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.exger.2010.08.016","article-title":"Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8)","volume":"45","author":"Cuesta","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed","volume":"2","author":"De la Monte","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3233\/JAD-2010-1321","article-title":"Early amyloid accumulation in the hippocampus of SAMP8 mice","volume":"19","author":"Del Valle","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/35096019","article-title":"A\u00a0decade of CDK5","volume":"2","author":"Dhavan","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine-threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib18","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1074\/jbc.272.31.19103","article-title":"A\u00a0requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation","volume":"272","author":"English","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib20","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.04-2572com","article-title":"Obesity-related leptin regulates Alzheimer\u2019s Abeta","volume":"18","author":"Fewlass","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer\u2019s disease","volume":"19","author":"Greco","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nlm.2004.03.005","article-title":"On the delay-dependent involvement of the hippocampus in object recognition memory","volume":"82","author":"Hammond","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12031-008-9174-3","article-title":"The Cdk5\/p35 kinases modulate leptin-induced STAT3 signaling","volume":"39","author":"He","year":"2009","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib25","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-5728(98)00132-5","article-title":"Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death","volume":"89","author":"Ho","year":"1998","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0","article-title":"Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer\u2019s disease","volume":"57","author":"Ho","year":"1999","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib29","doi-asserted-by":"crossref","first-page":"e24815","DOI":"10.1371\/journal.pone.0024815","article-title":"Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese","volume":"6","author":"Hou","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.neuroscience.2009.11.063","article-title":"Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse","volume":"165","author":"Huang","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.51.4.993","article-title":"Rate of medial temporal lobe atrophy in typical aging and Alzheimer\u2019s disease","volume":"51","author":"Jack","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer\u2019s disease?","author":"Jackson","year":"2013","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib33","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1371\/journal.pbio.0060272","article-title":"Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus","volume":"6","author":"Jessberger","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0531-5565(96)00063-0","article-title":"Neuropathological studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory","volume":"32","author":"Kawamata","year":"1997","journal-title":"Exp Gerontol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib36","unstructured":"Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, A. A. Y., 2010. Amylin agonist for treating depression, anxiety disorder and schizophrenia. US Patent 2013\/0035294 A1."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib35","doi-asserted-by":"crossref","first-page":"18567","DOI":"10.1073\/pnas.0810137105","article-title":"Cdk5 is essential for adult hippocampal neurogenesis","volume":"105","author":"Lagace","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib37","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s11064-009-0024-7","article-title":"Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation","volume":"34","author":"Lee","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2009.09.001","article-title":"Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation","volume":"465","author":"Li","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib39","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib40","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1523\/JNEUROSCI.14-05-02893.1994","article-title":"Basal cortisol levels and cognitive deficits in human aging","volume":"14","author":"Lupien","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib41","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","article-title":"Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity","volume":"61","author":"May","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib42","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative Processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1532-5415.1993.tb07458.x","article-title":"Alterations in glucose metabolism in patients with Alzheimer's disease","volume":"41","author":"Meneilly","year":"1993","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/diab.39.5.639","article-title":"Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration","volume":"39","author":"Mitsukawa","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in\u00a0vitro and ex\u00a0vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib48","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1523\/JNEUROSCI.09-06-02151.1989","article-title":"Synaptogenesis in the rat suprachiasmatic nucleus demonstrated by electron microscopy and synapsin I immunoreactivity","volume":"9","author":"Moore","year":"1989","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib49","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0196-9781(91)90148-I","article-title":"Amylin decreases food intake in mice","volume":"12","author":"Morley","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/138161212799315795","article-title":"The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease","volume":"18","author":"Morley","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbadis.2011.11.015","article-title":"The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease","volume":"1822","author":"Morley","year":"2012","journal-title":"Biochimi. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib52","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jps.21197","article-title":"A\u00a0biophysical characterization of the peptide drug pramlintide ( AC137 ) using empirical phase diagrams","volume":"97","author":"Nonoyama","year":"2008","journal-title":"J.\u00a0Phram. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2008-15408","article-title":"From aging to Alzheimer's disease: unveiling \u201cthe switch\u201d with the senescence-accelerated mouse model (SAMP8)","volume":"15","author":"Pallas","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-956752","article-title":"Mild cognitive impairment: current research and clinical implications","volume":"27","author":"Petersen","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib56","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/gerona\/59.5.M478","article-title":"Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress","volume":"59","author":"Poon","year":"2004","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib58","doi-asserted-by":"crossref","first-page":"R340","DOI":"10.1152\/ajpregu.00380.2011","article-title":"Involvement of the extracellular signal-regulated kinase 1\/2 signaling pathway in amylin's eating inhibitory effect","volume":"302","author":"Potes","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib59","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/oby.2007.239","article-title":"Amylin and its relation to insulin and lipids in obese children before and after weight loss","volume":"15","author":"Reinehr","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archneurol.2008.581","article-title":"Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications","volume":"66","author":"Roth","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2007.09.035","article-title":"Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK","volume":"56","author":"Samuels","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib63","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib64","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.20-21-08177.2000","article-title":"Activation of ERK\/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning","volume":"20","author":"Schafe","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib65","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib66","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.410370609","article-title":"Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain","volume":"37","author":"Schipper","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In\u00a0vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib68","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0167-4943(94)90039-6","article-title":"A\u00a0novel murine model of aging, Senescence-Accelerated Mouse (SAM)","volume":"19","author":"Takeda","year":"1994","journal-title":"Arch. Gerontology Geriatrics"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer's disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib72","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/01.WNL.0000140291.86406.D1","article-title":"Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study","volume":"63","author":"Xu","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.10.076_bib73","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013005290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013005290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:22:54Z","timestamp":1759317774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013005290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0197458013005290"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.10.076","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.10.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}